UnitedHealth Group Incorporated $UNH Holdings Decreased by Lindenwold Advisors INC

Lindenwold Advisors INC lessened its stake in UnitedHealth Group Incorporated (NYSE:UNH) by 39.6% in the third quarter, HoldingsChannel.com reports. The institutional investor owned 5,250 shares of the healthcare conglomerate’s stock after selling 3,441 shares during the quarter. Lindenwold Advisors INC’s holdings in UnitedHealth Group were worth $1,813,000 at the end of the most recent reporting period.

Several other institutional investors and hedge funds have also made changes to their positions in UNH. Mirabella Financial Services LLP raised its holdings in UnitedHealth Group by 36.8% during the third quarter. Mirabella Financial Services LLP now owns 8,992 shares of the healthcare conglomerate’s stock worth $3,099,000 after purchasing an additional 2,420 shares in the last quarter. FNY Investment Advisers LLC increased its position in shares of UnitedHealth Group by 203.2% during the 3rd quarter. FNY Investment Advisers LLC now owns 15,672 shares of the healthcare conglomerate’s stock valued at $5,411,000 after purchasing an additional 10,503 shares during the period. Saranac Partners Ltd lifted its holdings in shares of UnitedHealth Group by 12.6% in the third quarter. Saranac Partners Ltd now owns 14,474 shares of the healthcare conglomerate’s stock valued at $4,998,000 after buying an additional 1,617 shares during the period. Strategic Investment Solutions Inc. IL grew its holdings in UnitedHealth Group by 766.0% during the third quarter. Strategic Investment Solutions Inc. IL now owns 1,732 shares of the healthcare conglomerate’s stock worth $598,000 after acquiring an additional 1,532 shares during the period. Finally, Severin Investments LLC bought a new stake in UnitedHealth Group in the third quarter worth about $598,000. 87.86% of the stock is currently owned by institutional investors.

UnitedHealth Group Price Performance

Shares of NYSE:UNH opened at $280.35 on Friday. The business has a fifty day simple moving average of $298.52 and a 200 day simple moving average of $324.39. The company has a current ratio of 0.79, a quick ratio of 0.79 and a debt-to-equity ratio of 0.72. UnitedHealth Group Incorporated has a 1 year low of $234.60 and a 1 year high of $606.36. The firm has a market cap of $254.47 billion, a price-to-earnings ratio of 21.25, a P/E/G ratio of 1.31 and a beta of 0.41.

UnitedHealth Group (NYSE:UNH) last posted its quarterly earnings results on Tuesday, January 27th. The healthcare conglomerate reported $2.11 earnings per share for the quarter, topping analysts’ consensus estimates of $2.09 by $0.02. The company had revenue of $113.73 billion during the quarter, compared to the consensus estimate of $113.38 billion. UnitedHealth Group had a return on equity of 14.79% and a net margin of 2.69%.The business’s quarterly revenue was up 12.3% on a year-over-year basis. During the same period last year, the business earned $6.81 EPS. UnitedHealth Group has set its FY 2026 guidance at 17.750- EPS. As a group, sell-side analysts predict that UnitedHealth Group Incorporated will post 29.54 earnings per share for the current fiscal year.

UnitedHealth Group Dividend Announcement

The firm also recently announced a quarterly dividend, which was paid on Tuesday, March 17th. Shareholders of record on Monday, March 9th were given a $2.21 dividend. This represents a $8.84 annualized dividend and a yield of 3.2%. The ex-dividend date of this dividend was Monday, March 9th. UnitedHealth Group’s payout ratio is currently 67.02%.

Analyst Ratings Changes

UNH has been the topic of several recent research reports. Leerink Partners lowered their price objective on shares of UnitedHealth Group from $410.00 to $345.00 and set an “outperform” rating on the stock in a research note on Wednesday, January 28th. Barclays decreased their price target on shares of UnitedHealth Group from $391.00 to $327.00 and set an “overweight” rating on the stock in a research report on Friday, January 30th. Evercore upgraded UnitedHealth Group to a “strong-buy” rating in a research report on Tuesday, January 6th. KeyCorp reaffirmed an “overweight” rating on shares of UnitedHealth Group in a research report on Wednesday, January 28th. Finally, JPMorgan Chase & Co. decreased their price target on UnitedHealth Group from $425.00 to $389.00 and set an “overweight” rating for the company in a research report on Monday, February 2nd. One research analyst has rated the stock with a Strong Buy rating, seventeen have given a Buy rating, eight have given a Hold rating and two have assigned a Sell rating to the stock. According to MarketBeat.com, the company currently has a consensus rating of “Moderate Buy” and an average price target of $372.13.

UnitedHealth Group Company Profile

UnitedHealth Group Inc is a diversified health care company headquartered in Minnetonka, Minnesota, that operates two primary business platforms: UnitedHealthcare and Optum. Founded in 1977, the company provides a broad range of health benefits and health care services to individuals, employers, governmental entities and other organizations. Its operations span commercial employer-sponsored plans, individual and Medicare and Medicaid programs, and services for customers and health systems in the United States and selected international markets.

UnitedHealthcare is the company’s benefits business, administering health plans and networks, managing provider relationships, and offering coverage products for employers, individuals, and government-sponsored programs.